WallStSmart

Moelis & Co (MC)vsNomura Holdings Inc ADR (NMR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Nomura Holdings Inc ADR generates 148002% more annual revenue ($2.33T vs $1.57B). NMR leads profitability with a 17.3% profit margin vs 14.5%. NMR appears more attractively valued with a PEG of 0.82. NMR earns a higher WallStSmart Score of 84/100 (A-).

MC

Buy

63

out of 100

Grade: C+

Growth: 7.3Profit: 8.5Value: 5.0Quality: 7.0
Piotroski: 4/9Altman Z: 1.57

NMR

Exceptional Buy

84

out of 100

Grade: A-

Growth: 10.0Profit: 7.0Value: 7.0Quality: 3.0
Piotroski: 4/9Altman Z: 0.53

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MC1 strengths · Avg: 10.0/10
Return on EquityProfitability
45.4%10/10

Every $100 of equity generates 45 in profit

NMR6 strengths · Avg: 9.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Operating MarginProfitability
30.8%10/10

Strong operational efficiency at 30.8%

Revenue GrowthGrowth
31.2%10/10

Revenue surging 31.2% year-over-year

PEG RatioValuation
0.828/10

Growing faster than its price suggests

P/E RatioValuation
12.8x8/10

Attractively priced relative to earnings

EPS GrowthGrowth
42.0%8/10

Earnings expanding 42.0% YoY

Areas to Watch

MC3 concerns · Avg: 4.0/10
PEG RatioValuation
1.974/10

Expensive relative to growth rate

Price/BookValuation
9.4x4/10

Trading at 9.4x book value

Altman Z-ScoreHealth
1.574/10

Distress zone — elevated risk

NMR2 concerns · Avg: 1.5/10
Altman Z-ScoreHealth
0.532/10

Distress zone — elevated risk

Debt/EquityHealth
9.181/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : MC

The strongest argument for MC centers on Return on Equity. Revenue growth of 12.0% demonstrates continued momentum.

Bull Case : NMR

The strongest argument for NMR centers on Price/Book, Operating Margin, Revenue Growth. Profitability is solid with margins at 17.3% and operating margin at 30.8%. Revenue growth of 31.2% demonstrates continued momentum.

Bear Case : MC

The primary concerns for MC are PEG Ratio, Price/Book, Altman Z-Score.

Bear Case : NMR

The primary concerns for NMR are Altman Z-Score, Debt/Equity. Debt-to-equity of 9.18 is elevated, increasing financial risk.

Key Dynamics to Monitor

MC profiles as a value stock while NMR is a growth play — different risk/reward profiles.

MC carries more volatility with a beta of 1.84 — expect wider price swings.

NMR is growing revenue faster at 31.2% — sustainability is the question.

Monitor CAPITAL MARKETS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

NMR scores higher overall (84/100 vs 63/100), backed by strong 17.3% margins and 31.2% revenue growth. Both earn "Exceptional Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Moelis & Co

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Moelis & Company is an investment banking advisory firm in the United States, Europe, and internationally. The company is headquartered in New York, New York.

Nomura Holdings Inc ADR

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Nomura Holdings, Inc. provides various financial services to individuals, corporations, financial institutions, governments, and government agencies worldwide. The company is headquartered in Tokyo, Japan.

Want to dig deeper into these stocks?